World Pharma Today
World Pharma Today Linkedin Page World Pharma Today Facebook Page World Pharma Today Twitter Page DOWNLOAD
MEDIAPACK
Click here to BLOCK YOUR CONTENT SPACE IN OUR NEXT ISSUES
boracorpcdmo
News and Press Releases

Air Charter Service delivers millions of critical test kits to Australia.

Over the past six weeks, leading aircraft specialist, Air Charter Service, has arranged more than 65 charter flights carrying 3,000 tonnes from China to Australia. Each flight had more than one million..

READ MORE


Takeda partners with Engitix to to develop new anti-fibrotic therapies.

Engitix Ltd, a biotechnology company developing a portfolio of programmes in fibrosis and solid tumours using its proprietary human extracellular matrix platform, entered into an agreement with Takeda to expand an existing collaboration...

READ MORE

Thermo Fisher Scientific Launches New GMP-manufactured Cas9 Protein.

As researchers using genome editing tools move from basic research to clinical settings, high-quality ancillary materials and documentation are critical. To help researchers meet stringent quality...

READ MORE


Bora Pharmaceuticals to expand operations with $10m+ investment.

Fast-growing contract development and manufacturing organization BORA Pharmaceuticals, has announced a planned investment of $10 million to expand its Oral Solid Dose capabilities across facilities in Zhunan...

READ MORE
COVID-19 Updates

Is It Really Possible To Attain COVID-19 Herd Immunity?.

The fresh, new, astonishingly efficient COVID-19 vaccines were rolling out across the US this time last year, injecting a strong note of confidence into the country's formerly stumbling pandemic response...

READ MORE


Takeda Announces Approval of Nuvaxovid COVID-19 Vaccine for Primary and Booster Immunization in Japan

Takeda announced that it has received manufacturing and marketing approval from the Japan Ministry of Health, Labour and Welfare for Nuvaxovid Intramuscular Injection, a novel recombinant protein-based COVID-19 vaccine...

READ MORE

Covaxin Trials In The United States Have Been Put On Hold.

The phase 2/3 clinical trials for Bharat Biotech's COVID-19 vaccine, Covaxin, in the United States have been halted by the US Food and Drug Administration. As per a press release from Ocugen Inc...

READ MORE


boracorpcdmo


Advertising:

kathryn@worldpharmatoday.com

Phone: + 91 88268 49084


For the latest visit: https://www.worldpharmatoday.com/

World Pharma Today



We respect your privacy, view our privacy policy to understand how we use data.
{unsubscribe}Click Here{/unsubscribe} to Unsubscribe from This List, Manage or Block Receiving Any Further E-mails From Us |
{confirm}Re-confirm Your Subscription {/confirm}